We provide actionable answers from pre-clinical to post-launch. What can Norstella help you with? https://ow.ly/acO550PQWIE #Pipeline2Patient #Answers4Pharma #Pharma Citeline, Evaluate Ltd, MMIT (Managed Markets Insight & Technology), Panalgo, The Dedham Group
Norstella
Information Services
Yardley, PA 63,231 followers
We're on a mission to improve patient access to therapy.
About us
Norstella is a group of prominent pharmaceutical solutions providers – Citeline, Evaluate, MMIT, Panalgo, The Dedham Group – that help clients navigate complexities at each step of the drug development life cycle, from pipeline to patient.
- Website
-
http://www.norstella.com
External link for Norstella
- Industry
- Information Services
- Company size
- 1,001-5,000 employees
- Headquarters
- Yardley, PA
- Type
- Privately Held
Locations
-
Primary
Yardley, PA 19067, US
Employees at Norstella
Updates
-
The latest quarterly Gene, Cell & RNA Therapy Landscape Report by Citeline and the association with the American Society of Gene & Cell Therapy highlights significant growth in cell and gene therapies. https://lnkd.in/gX5Pr4x9 With over 4,000 therapies in development, including a notable increase in Phase I, II, and III programs, the potential to address unmet medical needs is expanding rapidly. Oncology remains a key focus, but there's also seeing a rise in non-oncology applications. Click the link in this post to read the full article. #Pipeline2Patient #FollowNorstella
-
Conference Catch-Up: LSX World Congress USA 2024 - Listen now: https://ow.ly/kYST50TCi0f Join Janelle Hart, Managing Editor at Citeline, in discussing key takeaways from LSX World Congress USA 2024. In this episode, Janelle chats with Tony Shi, MPH, Principal and Head of Digital Health and Access Innovation Strategy, and Eric Boyda, Consultant at The Dedham Group. They dive into insights from this two-day event, highlighting the latest in digital therapeutics. Discover the challenges and opportunities shaping the future of healthcare technology, from groundbreaking innovations to strategic investments and transformative partnerships.
-
Pharmaceutical companies spent $300 billion on research and development in 2023, but budgets are now under increased pressure. Research and development margins are expected to decrease from 30% of revenues for the remainder of the decade. In a time when every dollar is important, drug developers need to stand out through a combination of strategy and technology. Discover more insights in this article: https://ow.ly/Rf1J50TAkLB.
-
Explore the forefront of pharmaceutical innovation with Norstella's September roundup, featuring cutting-edge insights from industry trailblazers and learn about our brands' latest news and updates. Check out the links below.👇 Stay ahead of the curve in oncology with Norstella's new ebook, 'The Next Wave in Oncology.' Norstella's experts delve into the transformative impact of ADCs, CAR T-cell therapies, and digital advancements in clinical trials. Download your copy now: https://ow.ly/jC6m50TA7B8. Last year was a hot pharma year for new active substances (NASs), but there are a few rain clouds forecasted. Citeline's reports, infographics, audiobook and webinar help determine where the outlook is sunny and where clouds are forming. Explore them here: https://ow.ly/hMEn50TA7B9. With obesity treatments gaining ground, the next big questions are emerging. How big could the market get? Will incretins continue to dominate? And where are investors looking? Get the answers in Evaluate Ltd's infographic, powered by data from Evaluate Omnium: https://ow.ly/GVkm50TA7B6. How can pharma companies improve the accuracy, timeliness and relevance of the coverage data they share on their brand sites? MMIT's MMIT (Managed Markets Insight & Technology) 's Allison Vogel examines each method's benefits and drawbacks and shares best practices for physician education. Get the insights here: https://ow.ly/crHO50TA7B4. Panalgo has announced the launch of IHD Cloud, a cutting-edge solution powered by Amazon Web Services that will transform how organizations manage and use real-world data to generate real-world evidence. Read more here: https://ow.ly/y20X50TA7B7. As the IRA reshapes the healthcare environment, manufacturers and life sciences organizations have a unique opportunity to be at the forefront of patient support. In this article from The Dedham Group, Rebecca Leemputte explains the challenges and opportunities heading into 2025. Read it here: https://ow.ly/ukrB50TA7B5. Follow our brands to stay up with the latest news, insights, and updates. #Pipeline2Patient #FollowNorstella
-
Employee Spotlight Series: Meet Sarah Howard! https://ow.ly/zyzf50TuCNr Have you ever wondered who keeps the gears turning at Norstella’s Evaluate Ltd? Meet Sarah Howard, our outstanding Commercial Support Manager! Since 2007, Sarah has been the go-to person for managing sales support, reviewing contracts, and ensuring everything is legally sound. In January 2024, she took on an exciting new role in the commercial operations team, where she continues to support our sales and commercial teams with her expertise. Want to get to know Sarah better and hear her story? Dive into the Q&A with Sarah on our blog.
-
🌟 Employee Spotlight Series: Meet Benjamin Hinton II, PharmD, RPh! 🌟 https://ow.ly/fugE50Tkr6S We're excited to highlight Benjamin Hinton, our Senior Market Access Solutions Analyst and a passionate member of our Diversity, Equity, Inclusion, and Belonging Board. Benjamin’s journey at Norstella is nothing short of inspiring. In just three years, he has: • Joined the DE&I Board: Actively pushing initiatives to build out a place where employees feel like they belong and feel empowered. • Mentored Interns: Sharing his knowledge and enthusiasm with the next generation. • Collaborated Across Departments: Ensuring our solutions are communicated effectively. With his pharmacy background and infectious spirit, Benjamin embodies Norstella’s culture of empowerment and people-driven change in life sciences. Want to know more about Benjamin’s story? Check out the Q&A at the link in this post! #Pipeline2Patient #FollowNorstella
-
Patient access is a critical challenge in the US pharma industry, impacting the pace of drug development and the delivery of life-saving treatments. To assess the current state of patient access, Norstella’s MMIT (Managed Markets Insight & Technology) surveyed over 300 industry professionals to uncover key trends and challenges. Watch this video to discover the survey’s key findings, and download the full MMIT Patient Access Report: https://ow.ly/I2iR50Tqrc1. #Pipeline2Patient #FollowNorstella
-
Norstella reposted this
I love what I do because it makes me happy AND provides me the opportunity to pursue my passions (at and away from my desk). The right job doesn’t just pay the bills - it inspires creativity, fosters growth, and provides the flexibility to explore 🏔️ I’m so grateful to focus fully on my career while also dedicating time to things that fill my cup. Thankful for this journey and the people who inspire me every day ❤️
-
Norstella reposted this
Introducing the Market Access Monthly Newsletter. Subscribe to receive cutting-edge insights from MMIT’s top experts on the latest developments in market access–delivered seamlessly to your LinkedIn notifications and inbox.